UPDATE: Safeguard Scientifics has recalculated that health IT could grow to one-quarter of its investments. Safeguard Scientifics (NYSE:SFE ) Executive Vice President Jim Datin said its investments in health IT could grow from just under one-tenth to one-quarter, in an interview with MedCity News. The Wayne, Pennsylvania company recently consolidated the management of its life […]
The managing director of Safeguard Scientifics (NYSE: SFE) life sciences portfolio, Jim Datin, has taken over management of the technology portfolio in what was described as a strategic move by the venture capital firm reflecting the acceleration of health IT and medical devices with technology components. Kevin Kemmerer, who led the firm’s technology portfolio, resigned, […]
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!